PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20671266-7	2010	Knockdown of Notch3 resulted in sensitization to carboplatin in OVCAR3 that expresses abundant Notch3.	Carboplatin	49-60	notch receptor 3	Homo sapiens	13-19	
20671266-0	2010	Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin.	Carboplatin	95-106	notch receptor 3	Homo sapiens	0-6	
20671266-5	2010	Ectopic expression of the Notch3 intracellular domain led to an increase in IC(50) for carboplatin in an ovarian surface epithelial cell line and in a low-grade serous carcinoma cell line that expressed undetectable levels of Notch3.	Carboplatin	87-98	notch receptor 3	Homo sapiens	26-32	
20671266-7	2010	Knockdown of Notch3 resulted in sensitization to carboplatin in OVCAR3 that expresses abundant Notch3.	Carboplatin	49-60	notch receptor 3	Homo sapiens	95-101	
30723507-2	2019	Several studies demonstrate that Notch3 expression renders cancer cells more resistant to carboplatin, contributing to chemoresistance and poor survival of OC-bearing patients.	Carboplatin	90-101	notch receptor 3	Homo sapiens	33-39	
25010594-0	2014	Methylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatin.	Carboplatin	81-92	notch receptor 3	Homo sapiens	32-38	
25010594-4	2014	Overexpression of NICD3 (the constitutively active form of Notch3) in OVCA429 ovarian cancer cells (OVCA429/NICD3) renders them resistance to carboplatin treatment compared to OVCA429/pCEG cells expressing an empty vector.	Carboplatin	142-153	notch receptor 3	Homo sapiens	59-65	
23542683-0	2013	Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.	Carboplatin	64-75	notch receptor 3	Homo sapiens	0-6	
23542683-2	2013	Here, we investigated the role of Notch3 in carboplatin-induced apoptosis in ovarian cancer cells.	Carboplatin	44-55	notch receptor 3	Homo sapiens	34-40	
23542683-9	2013	Furthermore, Notch3 activation renders OVCA429 cells more resistant to carboplatin-induced cytotoxicity and attenuates carboplatin-induced apoptosis in these cells.	Carboplatin	71-82	notch receptor 3	Homo sapiens	13-19	
23542683-9	2013	Furthermore, Notch3 activation renders OVCA429 cells more resistant to carboplatin-induced cytotoxicity and attenuates carboplatin-induced apoptosis in these cells.	Carboplatin	119-130	notch receptor 3	Homo sapiens	13-19	
23542683-11	2013	Interestingly, carboplatin-induced ERK phosphorylation is inhibited by Notch3 activation.	Carboplatin	15-26	notch receptor 3	Homo sapiens	71-77	
23542683-12	2013	CONCLUSIONS: Notch3 activation induces EMT and attenuates carboplatin-induced apoptosis in OVCA429 cells.	Carboplatin	58-69	notch receptor 3	Homo sapiens	13-19	
23542683-14	2013	Interestingly, Notch3 activation attenuates carboplatin-induced ERK phosphorylation in these cells.	Carboplatin	44-55	notch receptor 3	Homo sapiens	15-21